Literature DB >> 15682478

Disturbance of hepatic and intestinal microcirculation in experimental liver cirrhosis.

Sasa-Marcel Maksan1, Eduard Ryschich, Zilfi Ulger, Martha Maria Gebhard, Jan Schmidt.   

Abstract

AIM: To analyze hepatic, mesenteric and mucosal microcirculation and leukocyte-endothelium interaction (LEI) in a rat model with liver cirrhosis.
METHODS: Hepatic cirrhosis was induced in Wistar rats by gavage with carbon tetrachloride, and intravital videomicroscopy was performed in liver, mesentery and small intestine mucosa. Special emphasis is given on microcirculatory and morphometric changes during cirrhotic portal hypertension.
RESULTS: LEI was influenced significantly in the cirrhotic liver but not in the gut. Blood flow measurement showed significant differences among liver, main mesenteric vessels and the mucosa. The results of our study indicate that liver cirrhosis leads to alterations in hepatic and mesenteric blood flow but not in mucosal blood flow.
CONCLUSION: The enhanced inflammatory response in hepatic microvessels may be caused by a decrease of antithrombin III levels and could be responsible for disturbances of organ pathology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15682478      PMCID: PMC4250594          DOI: 10.3748/wjg.v11.i6.846

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Increased blood flow through the portal system in cirrhotic rats.

Authors:  J Vorobioff; J E Bredfeldt; R J Groszmann
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

2.  Leukocyte adhesion and hepatic microvascular responses to intestinal ischemia/reperfusion in rats.

Authors:  Y Horie; R Wolf; M Miyasaka; D C Anderson; D N Granger
Journal:  Gastroenterology       Date:  1996-09       Impact factor: 22.682

Review 3.  The anti-inflammatory properties of antithrombin III: new therapeutic implications.

Authors:  K Okajima; M Uchiba
Journal:  Semin Thromb Hemost       Date:  1998       Impact factor: 4.180

4.  Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease.

Authors:  A Parlesak; C Schäfer; T Schütz; J C Bode; C Bode
Journal:  J Hepatol       Date:  2000-05       Impact factor: 25.083

5.  Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit.

Authors:  R G Shellman; W J Fulkerson; E DeLong; C A Piantadosi
Journal:  Crit Care Med       Date:  1988-07       Impact factor: 7.598

Review 6.  Pathophysiology, diagnosis and treatment of ascites in cirrhosis.

Authors:  Vicente Arroyo
Journal:  Ann Hepatol       Date:  2002 Apr-Jun       Impact factor: 2.400

7.  Standardized micronodular cirrhosis in the rat.

Authors:  E Proctor; K Chatamra
Journal:  Eur Surg Res       Date:  1984       Impact factor: 1.745

8.  Intestinal permeability is increased in patients with advanced cirrhosis.

Authors:  Sonia Pascual; José Such; Angel Esteban; Pedro Zapater; Juan A Casellas; José R Aparicio; Eva Girona; Ana Gutiérrez; Fernando Carnices; Jose M Palazón; Javier Sola-Vera; Miguel Pérez-Mateo
Journal:  Hepatogastroenterology       Date:  2003 Sep-Oct

9.  Hepatic and mesenteric nitric oxide synthase expression in a rat model of CCl(4)-induced cirrhosis.

Authors:  E K Bhimani; F Serracino-Inglott; A I Sarela; J J Batten; R T Mathie
Journal:  J Surg Res       Date:  2003-07       Impact factor: 2.192

10.  Hepatic microvascular changes associated with development of liver fibrosis and cirrhosis.

Authors:  I A Sherman; S C Pappas; M M Fisher
Journal:  Am J Physiol       Date:  1990-02
View more
  7 in total

1.  Changing common sense: Anti-platelet/coagulation therapy against cirrhosis.

Authors:  Yoshihiro Ikura; Tatsuya Osuga
Journal:  World J Hepatol       Date:  2015-07-08

2.  Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection.

Authors:  Astrit R Hamza; Avdyl S Krasniqi; Pramod Kadaba Srinivasan; Mamdouh Afify; Christian Bleilevens; Uwe Klinge; René H Tolba
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

3.  Restrictive model of compensated carbon tetrachloride-induced cirrhosis in rats.

Authors:  Jean-Marc Regimbeau; David Fuks; Niaz Kohneh-Shahri; Benoît Terris; Olivier Soubrane
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

4.  High-resolution three-dimensional visualization of hepatic sinusoids in cirrhotic rats via serial histological sections.

Authors:  Jing-Yi Liu; Wen-Juan Lv; Jian-Bo Jian; Xiao-Hong Xin; Xin-Yan Zhao; Chun-Hong Hu
Journal:  Histol Histopathol       Date:  2021-04-14       Impact factor: 2.303

Review 5.  Inflammation: a way to understanding the evolution of portal hypertension.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Arturo Cruz; Jaime Arias
Journal:  Theor Biol Med Model       Date:  2007-11-13       Impact factor: 2.432

6.  Intestinal microbial variation may predict early acute rejection after liver transplantation in rats.

Authors:  Zhigang Ren; Jianwen Jiang; Haifeng Lu; Xinhua Chen; Yong He; Hua Zhang; Haiyang Xie; Weilin Wang; Shusen Zheng; Lin Zhou
Journal:  Transplantation       Date:  2014-10-27       Impact factor: 4.939

7.  Upregulated expression of hypoxia reactive genes in peripheral blood mononuclear cells from chronic liver disease patients.

Authors:  Akifumi Kuwano; Masatake Tanaka; Hideo Suzuki; Miho Kurokawa; Koji Imoto; Shigeki Tashiro; Takeshi Goya; Motoyuki Kohjima; Masaki Kato; Yoshihiro Ogawa
Journal:  Biochem Biophys Rep       Date:  2021-07-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.